ProfileGDS5822 / ILMN_1216823
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 47% 79% 73% 35% 74% 51% 76% 65% 67% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 120.647
GSM1276600PDAC Late Ablation Control 2130.279
GSM1276601PDAC Late Ablation Control 396.473
GSM1276602PDAC Late Ablation 114.635
GSM1276603PDAC Late Ablation 284.174
GSM1276604PDAC Late Ablation 324.651
GSM1303940PDAC Late Ablation_anti-CTLA4 188.576
GSM1303941PDAC Late Ablation_anti-CTLA4 247.665
GSM1303942PDAC Late Ablation_anti-CTLA4 355.467